News

Video December 7, 2023

2023 Ogawa-Yamanaka Stem Cell Prize Awarded to Magdalena Zernicka-Goetz, PhD

Awards Ogawa Stem Cell Prize Stem Cells/iPSCs

Article November 17, 2023

Enchanted by the Earliest Stages of Human Life

Magdalena Zernicka-Goetz, recipient of the 2023 Ogawa-Yamanaka Stem Cell Prize, has created self-assembling embryo-like models that are advancing regenerative medicine

Awards Ogawa Stem Cell Prize Profile Stem Cells/iPSCs

Gladstone in the News November 7, 2023

Special Episode: JAHA Distinguished Hearts and Minds Roundtable

AHA with JAHA Podcast—In a roundtable forum, the American Heart Association’s 2023 Distinguished Scientists describe their contributions to stroke and cardiovascular research. Gladstone President Deepak Srivastava discusses the use of human iPS cells in drug discovery and his hopes for the future of science and medicine, including applications of artificial intelligence.

Gladstone Experts Congenital Heart Disease Cardiovascular Disease Srivastava Lab Human Genetics Stem Cells/iPSCs

Article September 27, 2023

When Two Disruptive Technologies Converge

How gene editing and stem cells are working in tandem at Gladstone Institutes to change science and medicine

Deep Dive Stem Cells/iPSCs CRISPR/Gene Editing Srivastava Lab Yamanaka Lab Doudna Lab Conklin Lab Marson Lab Huang Lab Ott Lab

Gladstone in the News September 18, 2023

CRISPR Cures for Cancer: Partnership to Accelerate Cell Therapy Using Genomics

UCSF News—Gladstone Senior Investigators Alex Marson and Jennifer Doudna, and President of the UC San Francisco Helen Diller Family Comprehensive Cancer Center Alan Ashworth, will head the newly launched CRISPR Cures for Cancer Initiative, which will fund research at the intersection of genomic technologies and cellular immunotherapies at Gladstone Institutes, UC San Francisco, and the Innovative Genomics Institute at UC Berkeley.

Gladstone Experts Cancer Data Science and Biotechnology Genomic Immunology Doudna Lab Marson Lab CRISPR/Gene Editing Stem Cells/iPSCs

Article August 2, 2023

“A Molecular Biology Tour de Force:” Pinpointing a Heart-Protective DNA Change

A Q&A with researchers Bruce Conklin and Juan Perez-Bermejo

Research (Publication) Mass Spectrometry Facility Heart Failure Data Science and Biotechnology Conklin Lab Krogan Lab Stem Cells/iPSCs

Article July 17, 2023

A Key Function for Tight Junctions in Embryo Models

Barriers between stem cells play a crucial role in human development—and offer a new potential route for fertility treatment

News Release Research (Publication) iPS Cell Research Center Yamanaka Lab Stem Cells/iPSCs

Article June 27, 2023

The 2023 Ogawa-Yamanaka Stem Cell Prize Awarded to Magdalena Zernicka-Goetz

Zernicka-Goetz has created embryo models from stem cells and opened up new possibilities for regenerative medicine

Awards Institutional News News Release Ogawa Stem Cell Prize Stem Cells/iPSCs

Gladstone in the News March 23, 2023

The Personalized Stem Cells That Could One Day Treat Parkinson’s and Heart Failure

The Wall Street Journal—Induced pluripotent stem cells have the potential to be used in innovative therapies for conditions like for Parkinson’s disease, macular degeneration, and heart failure. Gladstone Senior Investigator Shinya Yamanaka, who was the first to develop the technology, describes how a patient’s own cells can be used to generate tissue for transplantation.

Gladstone Experts Yamanaka Lab Stem Cells/iPSCs

Video December 1, 2022

2022 Ogawa-Yamanaka Stem Cell Prize Ceremony

Watch Juan Carlos Izpisua Belmonte present his award-winning work during the 2022 Ogawa-Yamanaka Stem Cell Prize Ceremony

Ogawa Stem Cell Prize Stem Cells/iPSCs

Article November 29, 2022

Rewinding Cells to Reverse Disease

Juan Carlos Izpisua Belmonte, recipient of the 2022 Ogawa-Yamanaka Stem Cell Prize, is turning back the clock on old and sick cells, with many potential benefits

Awards Ogawa Stem Cell Prize Profile Stem Cells/iPSCs

Article November 22, 2022

15 Years Later: This Is How Scientists Are Using Induced Pluripotent Stem Cells

Gladstone researchers talk about the power of iPS cells in biomedical research

Stem Cells/iPSCs Cardiovascular Disease Stem Cell Core

Gladstone in the News November 3, 2022

Medical Milestones Are Underway at San Francisco’s Gladstone Institutes

Nob Hill Gazette—Home to 30 labs and 500 researchers, Gladstone is a hub of cutting-edge research and advances toward cures for the most devastating diseases.

Gladstone Experts Doudna Lab Greene Lab Ott Lab Srivastava Lab Weinberger Lab Yamanaka Lab Big Data CRISPR/Gene Editing Stem Cells/iPSCs

Article June 24, 2022

The 2022 Ogawa-Yamanaka Stem Cell Prize Awarded to Juan Carlos Izpisua Belmonte

Izpisua Belmonte is recognized for his innovative work in programming cellular rejuvenation

Awards Institutional News News Release Ogawa Stem Cell Prize Stem Cells/iPSCs

Gladstone in the News March 9, 2022

Disease in a Dish: What Mini-Hearts and Other Organs Reveal about Long COVID

San Jose Mercury News—Senior Investigators Melanie Ott, MD, PhD, and Bruce Conklin, MD, recount how they used miniature balls of beating heart cells called organoids to study the effects of COVID-19 on the heart. The heart cells were derived from a person's skin cells, thanks to technology pioneered by Senior Investigator and Nobel Laureate Shinya Yamanaka, MD, PhD.

Gladstone Experts Stem Cell Core COVID-19 Cardiovascular Disease Data Science and Biotechnology Infectious Disease Conklin Lab Ott Lab Yamanaka Lab Organoids